Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

SHPro® improved urinary symptoms and erectile function in men and is safe.

Finasteride may decrease semen quality but not harm sperm production, and stopping the drug can improve semen quality; hyperprolactinemia can cause infertility but is treatable with medication.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Many patients with benign prostatic hyperplasia experience high anxiety and residual symptoms, needing better anxiety management.

Finasteride doesn't affect erections much, but may decrease libido in men.

Finasteride caused bleeding in a man, which stopped after stopping the drug.

Finasteride and SSRIs together increase impotence and low libido risk in men.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Hair loss in women linked to higher sexual dysfunction risk.

The meeting highlighted advances in sexual medicine and priapism management.

Flibanserin shows promise for treating male sexual dysfunction but has side effects like insomnia and fatigue.

Anabolic steroid abuse can cause sexual, fertility, and health problems.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Insufficient androgen action in male fetuses can cause genital development issues due to genetic mutations or environmental chemicals.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Dutasteride and finasteride can change semen and hormone levels in men.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Post-finasteride syndrome causes sexual, physical, and psychological symptoms, but more research is needed to understand its causes and connection to finasteride.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

EPDS can cause recurring scalp sores and hair loss if not treated.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Men with androgenetic alopecia do not have elevated DHEA-S levels.